NAUT News and Press, Nautilus Biotechnology Inc. From 08/02/23

2023-08-02 07:49:27 ET Nautilus Biotechnology press release ( NASDAQ: NAUT ): Q2 GAAP EPS of -$0.13 beats by $0.01 . Cash, cash equivalents, and investments were $286.7 million as of June 30, 2023. For further details see: Nautilus Biotechnology GAAP EPS...

SEATTLE, Wash., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2023. “I’m e...

2023-08-01 13:25:46 ET Nautilus Biotechnology ( NASDAQ: NAUT ) is scheduled to announce Q2 earnings results on Tuesday, August 2nd, before market open. The consensus EPS Estimate is -$0.16 (-33.3% Y/Y) and the consensus Revenue Estimate is $0M Over the last 3 months, E...

SEATTLE, July 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the second quarter before market open on Wednesday, August 2,...

SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences: Jefferies 2023 Hea...

2023-05-02 14:57:06 ET Nautilus Biotechnology, Inc. (NAUT) Q1 2023 Earnings Conference Call May 2, 2023 08:30 ET Company Participants Carrie Mendivil - Investor Relations Sujal Patel - Co-Founder, Chief Executive Officer, President, Secretary & Director Anna ...

2023-05-02 06:38:00 ET Nautilus Biotechnology press release ( NASDAQ: NAUT ): Q1 GAAP EPS of -$0.12 beats by $0.03 . Cash, cash equivalents, and investments were $302.0 million as of March 31, 2023. For further details see: Nautilus Biotechnology GAAP EP...

SEATTLE, May 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2023. Recent Highlights ...

2023-05-01 13:29:58 ET Nautilus Biotechnology ( NASDAQ: NAUT ) is scheduled to announce Q1 earnings results on Monday, May 1st, after market close. The consensus EPS Estimate is -$0.17 (-30.8% Y/Y) and the consensus Revenue Estimate is $0M Over the last 3 months, EPS e...

2023-04-27 18:01:59 ET Gainers: Mirati Therapeutics ( MRTX ) +10% . JAKKS Pacific ( JAKK ) +10% . Amazon.com ( AMZN ) +9% . Datadog ( DDOG ) +8% . Recursion Pharmaceuticals ( RXRX ) +6% . Losers: Accolade ( ACCD ) -...